Company intelligence / Profile preview
Integro Theranostics
St. Louis, Missouri, United Statesintegrotheranostics.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Integro Theranostics has initiated a Phase 1b/2 study to evaluate the safety, efficacy, and pharmacokinetics of LS301, a novel fluorescent imaging agent administered intravenously to women undergoing partial mastectomy or sentinel lymph node biopsy for DCIS or early-stage invasive breast cancer. The primary objective is safety; secondary objectives include efficacy based on real-time fluorescence-guided tumor visualization during surgery. No published top-line results as of May 2025.
- Therapeutic areas
- Oncology
- Modalities
- Fluorescent imaging agents (small molecule-based)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
OmniScience – partnership to integrate AI-powered image analysis and data management into oncology clinical trials using OmniScience’s Vivo platform.
Beyond the preview
Go deeper on Integro Theranostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Integro Theranostics.